These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 28971861

  • 1. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM, van der Elst KC, Veringa A, Jongedijk EM, Brüggemann RJ, Koster RA, Kampinga GA, Kosterink JG, van der Werf TS, Zijlstra JG, Touw DJ, Alffenaar JWC.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [Abstract] [Full Text] [Related]

  • 2. Low Caspofungin Exposure in Patients in Intensive Care Units.
    van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855112
    [Abstract] [Full Text] [Related]

  • 3. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
    Maseda E, Grau S, Luque S, Castillo-Mafla MP, Suárez-de-la-Rica A, Montero-Feijoo A, Salgado P, Gimenez MJ, García-Bernedo CA, Gilsanz F, Roberts JA.
    Crit Care; 2018 Apr 15; 22(1):94. PubMed ID: 29655372
    [Abstract] [Full Text] [Related]

  • 4. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
    Maseda E, Grau S, Villagran MJ, Hernandez-Gancedo C, Lopez-Tofiño A, Roberts JA, Aguilar L, Luque S, Sevillano D, Gimenez MJ, Gilsanz F.
    J Antimicrob Chemother; 2014 Jun 15; 69(6):1624-32. PubMed ID: 24505092
    [Abstract] [Full Text] [Related]

  • 5. Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.
    Lepak A, Castanheira M, Diekema D, Pfaller M, Andes D.
    Antimicrob Agents Chemother; 2012 Nov 15; 56(11):5875-82. PubMed ID: 22948870
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal Infections.
    Brüggemann RJ, Middel-Baars V, de Lange DW, Colbers A, Girbes AR, Pickkers P, Swart EL.
    Antimicrob Agents Chemother; 2017 Feb 15; 61(2):. PubMed ID: 27872072
    [Abstract] [Full Text] [Related]

  • 7. Micafungin Plasma Levels Are Not Affected by Continuous Renal Replacement Therapy: Experience in Critically Ill Patients.
    Vossen MG, Knafl D, Haidinger M, Lemmerer R, Unger M, Pferschy S, Lamm W, Maier-Salamon A, Jäger W, Thalhammer F.
    Antimicrob Agents Chemother; 2017 Aug 15; 61(8):. PubMed ID: 28584142
    [Abstract] [Full Text] [Related]

  • 8. Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients.
    Martial LC, Ter Heine R, Schouten JA, Hunfeld NG, van Leeuwen HJ, Verweij PE, de Lange DW, Pickkers P, Brüggemann RJ.
    Clin Pharmacokinet; 2017 Oct 15; 56(10):1197-1206. PubMed ID: 28144840
    [Abstract] [Full Text] [Related]

  • 9. Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.
    García-de-Lorenzo A, Luque S, Grau S, Agrifoglio A, Cachafeiro L, Herrero E, Asensio MJ, Sánchez SM, Roberts JA.
    Antimicrob Agents Chemother; 2016 Oct 15; 60(10):5914-21. PubMed ID: 27458229
    [Abstract] [Full Text] [Related]

  • 10. Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.
    Pérez-Pitarch A, Ferriols-Lisart R, Aguilar G, Ezquer-Garín C, Belda FJ, Guglieri-López B.
    Int J Antimicrob Agents; 2018 Jan 15; 51(1):115-121. PubMed ID: 28666752
    [Abstract] [Full Text] [Related]

  • 11. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.
    Arendrup MC, Perlin DS, Jensen RH, Howard SJ, Goodwin J, Hope W.
    Antimicrob Agents Chemother; 2012 May 15; 56(5):2435-42. PubMed ID: 22354305
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Altered Micafungin Pharmacokinetics in Intensive Care Unit Patients.
    Lempers VJ, Schouten JA, Hunfeld NG, Colbers A, van Leeuwen HJ, Burger DM, Verweij PE, Pickkers P, Brüggemann RJ.
    Antimicrob Agents Chemother; 2015 Aug 15; 59(8):4403-9. PubMed ID: 25963988
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
    Lepak AJ, Zhao M, Berkow EL, Lockhart SR, Andes DR.
    Antimicrob Agents Chemother; 2017 Aug 15; 61(8):. PubMed ID: 28584152
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic study of anidulafungin in ICU patients with intra-abdominal candidiasis.
    Dupont H, Massias L, Jung B, Ammenouche N, Montravers P.
    J Antimicrob Chemother; 2017 May 01; 72(5):1429-1432. PubMed ID: 28088767
    [Abstract] [Full Text] [Related]

  • 16. Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.
    van der Geest PJ, Hunfeld NG, Ladage SE, Groeneveld AB.
    BMC Infect Dis; 2016 Sep 15; 16():490. PubMed ID: 27634140
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.
    Grau S, Luque S, Campillo N, Samsó E, Rodríguez U, García-Bernedo CA, Salas E, Sharma R, Hope WW, Roberts JA.
    J Antimicrob Chemother; 2015 Oct 15; 70(10):2854-61. PubMed ID: 26180134
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.